https://www.selleckchem.com/products/Daidzein.html
To evaluate chest computed tomography (CT) and pulmonary function test (PFT) findings in severe COVID-19 patients after discharge and correlate CT pulmonary involvement with PFT results. COVID-19 patients admitted to our hospital between February 25 and May 2, 2020, were retrospectively included according to the following criteria (a) COVID-19 defined as severe based on the WHO interim guidance (i.e., clinical signs of pneumonia plus respiratory rate 30 breaths/min, severe respiratory distress, and/or SpO 90 % on room air); (
Curtir
Comentario
Compartilhar
